• ACC CardiaCast: Exploring HF&T Highlights from ACC.24: RELIEVE-HF, REDUCE AMI, and DANGER-Shock Trials

  • May 6 2024
  • Length: 19 mins
  • Podcast
ACC CardiaCast: Exploring HF&T Highlights from ACC.24: RELIEVE-HF, REDUCE AMI, and DANGER-Shock Trials cover art

ACC CardiaCast: Exploring HF&T Highlights from ACC.24: RELIEVE-HF, REDUCE AMI, and DANGER-Shock Trials

  • Summary

  • Dive into the Heart of ACC.24's Heart Failure and Transplant Highlights! In this podcast, Drs. Maya Guglin, Shelley Hall, Onyedika Ilonze, and Kazuhiko Kido dissect the most captivating advancements and groundbreaking revelations from the ACC.24 sessions in heart failure and transplant, including trials RELIEVE-HF, REDUCE-AMI, and DanGer Shock. Join us as we navigate through the latest research, innovative therapies, and paradigm-shifting insights that promise to reshape the landscape of cardiovascular medicine. Whether you're a seasoned clinician, researcher, or enthusiast, prepare to be inspired and informed as we unravel the future of cardiac care together!

    Educational grant support for ACC.24’s Learning Pathways and this podcast provided by Merck Sharp & Dohme Corp.

    Show More Show Less

What listeners say about ACC CardiaCast: Exploring HF&T Highlights from ACC.24: RELIEVE-HF, REDUCE AMI, and DANGER-Shock Trials

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.